BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yashiro M, Matsuoka T. Fibroblast growth factor receptor signaling as therapeutic targets in gastric cancer. World J Gastroenterol 2016; 22(8): 2415-2423 [PMID: 26937130 DOI: 10.3748/wjg.v22.i8.2415]
URL: https://www.wjgnet.com/1007-9327/full/v22/i8/2415.htm
Number Citing Articles
1
Ya-Kun Jiang, Wei Li, Ying-Yang Qiu, Meng Yue. Advances in targeted therapy for human epidermal growth factor receptor 2 positive in advanced gastric cancerWorld Journal of Gastrointestinal Oncology 2024; 16(6): 2318-2334 doi: 10.4251/wjgo.v16.i6.2318
2
Jun Wu, Wei Han, Weiwei Yang, Hongyu Liu, Chunhong Li, Ling Guo, Yan Jin, Ruijie Zhang, He Chen. Keratinocyte growth factor binding to fibroblast growth factor receptor 2-IIIb promotes epithelial ovarian cancer cell proliferation and invasionJournal of Cancer Research and Therapeutics 2018; 14(Suppl 2): S347 doi: 10.4103/0973-1482.235353
3
Vincenzo Canzonieri, Federica Rao, Tiziana Perin, Lara Alessandrini, Angela Buonadonna, Giulio Bertola, Claudio Belluco, Renato Cannizzaro, Antonino De Paoli, Antonio Giordano. Gastric Cancer In The Precision Medicine EraCurrent Clinical Pathology 2019; : 83 doi: 10.1007/978-3-030-04861-7_5
4
Z Ousati Ashtiani, J Tavakkoly-Bazzaz, SA Salami, MR Pourmand, F Mansouri, R Mashahdi, G Pourmand. Differential expression of FGFRs signaling pathway components in bladder cancer: A step toward personalized medicineBalkan Journal of Medical Genetics 2017; 20(2): 75 doi: 10.1515/bjmg-2017-0026
5
Tasuku Matsuoka, Masakazu Yashiro. Biomarkers of gastric cancer: Current topics and future perspectiveWorld Journal of Gastroenterology 2018; 24(26): 2818-2832 doi: 10.3748/wjg.v24.i26.2818
6
Navid Sobhani, Anna Ianza, Alberto D’Angelo, Giandomenico Roviello, Fabiola Giudici, Marina Bortul, Fabrizio Zanconati, Cristina Bottin, Daniele Generali. Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast CancerCells 2018; 7(7): 76 doi: 10.3390/cells7070076
7
Navid Sobhani, Chunmei Fan, Pedro O. Flores-Villanueva, Daniele Generali, Yong Li. The Fibroblast Growth Factor Receptors in Breast Cancer: from Oncogenesis to Better TreatmentsInternational Journal of Molecular Sciences 2020; 21(6): 2011 doi: 10.3390/ijms21062011
8
Loredana Amoroso, Marzia Ognibene, Martina Morini, Massimo Conte, Andrea Di Cataldo, Annalisa Tondo, Paolo D'Angelo, Aurora Castellano, Alberto Garaventa, Vito A. Lasorsa, Marina Podestà, Mario Capasso, Annalisa Pezzolo. Genomic coamplification of CDK4/MDM2/FRS2 is associated with very poor prognosis and atypical clinical features in neuroblastoma patientsGenes, Chromosomes and Cancer 2020; 59(5): 277 doi: 10.1002/gcc.22827
9
Marina Alekseevna Senchukova. Origen, morfología y significancia clínica de microvesículas de tumor en cáncer gástricoMagna Scientia UCEVA 2022; 2(1): 5 doi: 10.54502/msuceva.v2n1a2
10
Hideki Yamaguchi, Yuko Nagamura, Makoto Miyazaki. Receptor Tyrosine Kinases Amplified in Diffuse-Type Gastric Carcinoma: Potential Targeted Therapies and Novel Downstream EffectorsCancers 2022; 14(15): 3750 doi: 10.3390/cancers14153750
11
Giuseppe Tirino, Luca Pompella, Angelica Petrillo, Maria Maddalena Laterza, Annalisa Pappalardo, Marianna Caterino, Michele Orditura, Fortunato Ciardiello, Gennaro Galizia, Ferdinando De Vita. What’s New in Gastric Cancer: The Therapeutic Implications of Molecular Classifications and Future PerspectivesInternational Journal of Molecular Sciences 2018; 19(9): 2659 doi: 10.3390/ijms19092659
12
José Pedro Santos, Joana Figueiredo, José Carlos Machado. Gastric Cancer Genetics and Its Implications for Diagnosis, Prognosis, and Treatment of the DiseaseThe Korean Journal of Helicobacter and Upper Gastrointestinal Research 2024; 24(2): 103 doi: 10.7704/kjhugr.2024.0018
13
Hyunjin Kim, Sujin Park, So Young Kang, Soomin Ahn, Kyoung-Mee Kim. Peritoneal Seeding Is More Common in Gastric Cancer Patients with FGFR2 Amplification or High Tumor Mutation BurdenDiagnostics 2022; 12(10): 2355 doi: 10.3390/diagnostics12102355
14
Masaru Katoh. Fibroblast growth factor receptors as treatment targets in clinical oncologyNature Reviews Clinical Oncology 2019; 16(2): 105 doi: 10.1038/s41571-018-0115-y
15
Xin He, Zongguo Pang, Xianliang Zhang, Ting Lan, Huijiao Chen, Min Chen, Hong Yang, Juan Huang, Yihua Chen, Zhang Zhang, Wenyi Jing, Ran Peng, Hongying Zhang. Consistent Amplification of FRS2 and MDM2 in Low-grade OsteosarcomaAmerican Journal of Surgical Pathology 2018; 42(9): 1143 doi: 10.1097/PAS.0000000000001125
16
Ousman Mohammed, Solomon Tebeje Gizaw, Maria Degef. Potential diagnostic, prognostic, and predictive biomarkers of gastric cancerHealth Science Reports 2024; 7(7) doi: 10.1002/hsr2.2261
17
Waleed A. Mohamed, Mona F. Schaalan, Basma Ramadan. The expression profiling of circulating miR‐204, miR‐182, and lncRNA H19 as novel potential biomarkers for the progression of peptic ulcer to gastric cancerJournal of Cellular Biochemistry 2019; 120(8): 13464 doi: 10.1002/jcb.28620
18
Maria Bogdan, Andreea-Daniela Meca, Adina Turcu-Stiolica, Carmen Nicoleta Oancea, Roxana Kostici, Marin Valeriu Surlin, Cristina Florescu. Insights into the Relationship between Pentraxin-3 and CancerInternational Journal of Molecular Sciences 2022; 23(23): 15302 doi: 10.3390/ijms232315302
19
Charline M. Sangany, Jagidesa Moodley, Onankoy A. Onyagunga, Thajasvarie Naicker. Role of basic fibroblast growth factor in human immunodeficiency virus associated pre‐eclampsiaJournal of Obstetrics and Gynaecology Research 2020; 46(8): 1292 doi: 10.1111/jog.14335
20
Barani Karikalan, Srikumar Chakravarthi. Target Therapy and Immunotherapy for Gastric Cancer - Recent UpdatesCurrent Cancer Therapy Reviews 2022; 18(3): 202 doi: 10.2174/1573394718666220418095954
21
Fengjiao Wang, Xuexin Li, Xingkai Zhao, Yingwei Xue. Detection of a 5-circRNA signature to improve prognostic prediction in gastric cancerJournal of Investigative Medicine 2020; 68(3): 762 doi: 10.1136/jim-2019-001131
22
Kenji Kuroda, Masakazu Yashiro, Yuichiro Miki, Tomohiro Sera, Yurie Yamamoto, Atsushi Sugimoto, Sadaaki Nishimura, Shuhei Kushiyama, Shingo Togano, Tomohisa Okuno, Masaichi Ohira. Circulating tumor cells with FGFR2 expression might be useful to identify patients with existing FGFR2‐overexpressing tumorCancer Science 2020; 111(12): 4500 doi: 10.1111/cas.14654
23
Larissa Maria Scalon Lemos, Oluwakemi Adekunbi Ọlọ́ba-Whẹ̀nù, Idris Abiodun Olasupo, Sikiru Olaitan Balogun, Antonio Macho, Eduarda Pavan, Domingos Tabajara de Oliveira Martins. Brasiliensic acid: in vitro cytotoxic and genotoxic, in vivo acute toxicity and in silico pharmacological prediction of a new promising molecule Journal of Biomolecular Structure and Dynamics 2023; : 1 doi: 10.1080/07391102.2023.2280713
24
Salem Kim, Afsaneh Barzi, Lakshmi Rajdev. Biomarker-driven targeted therapies for gastric/gastro-esophageal junction malignanciesSeminars in Oncology 2018; 45(3): 133 doi: 10.1053/j.seminoncol.2018.03.001
25
D. S. Mikhaylenko, B. Y. Alekseev, D. V. Zaletaev, R. I. Goncharova, M. V. Nemtsova. Structural Alterations in Human Fibroblast Growth Factor Receptors in CarcinogenesisBiochemistry (Moscow) 2018; 83(8): 930 doi: 10.1134/S0006297918080059
26
Kate Crawford, Erin Bontrager, Margaret A. Schwarz, Apurva Chaturvedi, Daniel D. Lee, Hassan Md Sazzad, Urs von Holzen, Changhua Zhang, Roderich E. Schwarz, Niranjan Awasthi. Targeted FGFR/VEGFR/PDGFR inhibition with dovitinib enhances the effects of nab-paclitaxel in preclinical gastric cancer modelsCancer Biology & Therapy 2021; 22(10-12): 619 doi: 10.1080/15384047.2021.2011642
27
Sadaaki Nishimura, Masakazu Yashiro, Tomohiro Sera, Yurie Yamamoto, Yukako Kushitani, Atsushi Sugimoto, Shuhei Kushiyama, Shingo Togano, Kenji Kuroda, Tomohisa Okuno, Yoshiki Murakami, Masaichi Ohira. Serine threonine kinase 11/liver kinase B1 mutation in sporadic scirrhous-type gastric cancer cellsCarcinogenesis 2020; 41(11): 1616 doi: 10.1093/carcin/bgaa031
28
Marina A Senchukova. Issues of origin, morphology and clinical significance of tumor microvessels in gastric cancerWorld Journal of Gastroenterology 2021; 27(48): 8262-8282 doi: 10.3748/wjg.v27.i48.8262
29
Masakazu Yashiro, Kenji Kuroda, Go Masuda, Tomohisa Okuno, Yuichiro Miki, Yurie Yamamoto, Tomohiro Sera, Atsushi Sugimoto, Shuhei Kushiyama, Sadaaki Nishimura, Shingo Togano, Masaichi Ohira. Clinical difference between fibroblast growth factor receptor 2 subclass, type IIIb and type IIIc, in gastric cancerScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-84107-x